Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
|---|---|---|---|---|---|---|---|---|---|---|---|
| N2586 | IKK16 | 2.0 | uM | Leptin | 1 | ng/mL | 1 | MCP-1 (MCAF) | 6086.0 | 43 | |
| RA2159 | 1 | MCP-1 (MCAF) | 3285.0 | 59 | |||||||
| RA2159 | PD184352 | 0.1 | uM | 1 | MCP-1 (MCAF) | 2248.0 | 51 | ||||
| RA2159 | Lestaurtinib | 0.3 | uM | 1 | MCP-1 (MCAF) | 1712.0 | 67 | ||||
| RA2159 | Ruxolitinib | 0.3 | uM | 1 | MCP-1 (MCAF) | 2492.5 | 58 | ||||
| RA2159 | Tofacitinib | 0.3 | uM | 1 | MCP-1 (MCAF) | 2839.0 | 78 | ||||
| RA2159 | IKK16 | 2.0 | uM | 1 | MCP-1 (MCAF) | 1186.0 | 69 | ||||
| RA2159 | 1 | MCP-1 (MCAF) | 2754.0 | 76 | |||||||
| N2586 | 1 | MCP-1 (MCAF) | 6286.0 | 72 | |||||||
| N2586 | PD184352 | 0.1 | uM | 1 | MCP-1 (MCAF) | 5973.0 | 83 | ||||
| N2586 | Lestaurtinib | 0.3 | uM | 1 | MCP-1 (MCAF) | 5087.0 | 76 | ||||
| N2586 | Ruxolitinib | 0.3 | uM | 1 | MCP-1 (MCAF) | 6427.0 | 87 | ||||
| N2586 | Tofacitinib | 0.3 | uM | 1 | MCP-1 (MCAF) | 6473.0 | 65 | ||||
| N2586 | IKK16 | 2.0 | uM | 1 | MCP-1 (MCAF) | 4587.0 | 73 | ||||
| N2586 | 1 | MCP-1 (MCAF) | 6594.0 | 51 | |||||||
| RA2159 | Visfatin | 1 | ng/mL | 1 | MCP-1 (MCAF) | 2290.0 | 63 | ||||
| RA2159 | PD184352 | 0.1 | uM | Visfatin | 1 | ng/mL | 1 | MCP-1 (MCAF) | 1697.0 | 77 | |
| RA2159 | Lestaurtinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | MCP-1 (MCAF) | 2106.0 | 76 | |
| RA2159 | Ruxolitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | MCP-1 (MCAF) | 2988.0 | 78 | |
| RA2159 | Tofacitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | MCP-1 (MCAF) | 2590.0 | 49 | |
| RA2159 | IKK16 | 2.0 | uM | Visfatin | 1 | ng/mL | 1 | MCP-1 (MCAF) | 837.0 | 64 | |
| N2586 | Visfatin | 1 | ng/mL | 1 | MCP-1 (MCAF) | 5260.5 | 66 | ||||
| N2586 | PD184352 | 0.1 | uM | Visfatin | 1 | ng/mL | 1 | MCP-1 (MCAF) | 5765.0 | 68 | |
| N2586 | Lestaurtinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | MCP-1 (MCAF) | 5073.0 | 69 | |
| N2586 | Ruxolitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | MCP-1 (MCAF) | 5228.0 | 78 |